Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors for inhibitor formation in haemophilia: a prevalent case-control study.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 Sept 2009

Ragni M V, Ojeifo O, Feng J, Yan J, Hill K A, Sommer S S, Trucco M N, Brambilla D J

Abstract excerpt

Inhibitor formation is a major complication of haemophilia treatment. In a prevalent case-control study, we evaluated blood product exposure, genotype and HLA type on haemophilia A inhibitor formation. Product exposure was extracted from medical records. Genotype was determined on stored DNA samples by detection of virtually all mutations-SSCP (DOVAM-S) and subcycling PCR. HLA typing was performed by PCR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Anticoagulants

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Coagulation Factor Inhibitors

Share to Dose-Response Relationship, Drug

Share to Drug Administration Schedule

Share to Hemophilia A

Share to Infant

Share to Prevalence

Source

Open in PubMed Open full text

Identifiers

PMID: 19563499
DOI: 10.1111/j.1365-2516.2009.02058.x
PMCID: PMC2734871

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors for inhibitor formation in haemophilia: a prevalent case-control study.PMID 19563499Read ↗

Inhibitor development in hemophiliacs: the roles of genetic versus environmental factors.Semantic proximity Read ↗

The epidemiology of factor VIII inhibitors.Semantic proximity Read ↗

Inhibitors in haemophilia: pathophysiology.Semantic proximity Read ↗

Assessing risk factors: prevention of inhibitors in haemophilia.Semantic proximity Read ↗

Environmental and genetic factors influencing inhibitor development.Semantic proximity Read ↗

Genetic risk factors for inhibitors in haemophilia A.Semantic proximity Read ↗

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.Semantic proximity Read ↗

Risk factors for inhibitor development in hemophilia A.Semantic proximity Read ↗

Genetic risk factors for inhibitors to factors VIII and IX.Semantic proximity Read ↗

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet studySemantic proximity Read ↗

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.Semantic proximity Read ↗

Treatment related factors and inhibitor development in children with severe haemophilia A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.